Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Pandey

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|December 25, 2012
Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2)Craig E Hughes, Uma Sinha, Anjali Pandey, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2010
Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosisIvo Cornelissen, Daniel Palmer, Tovo David, et al.
RSC Advances|December 4, 2025
Preclinical validation of magnetic hyperthermia therapy for locally advanced oral cancer treatmentPriyadharshni Sriram, Anjali Pandey, Aganiya Gopalakrishnan, et al.
Phytotherapy Research : PTR|March 17, 2009
Amelioration of adjuvant induced arthritis by apocyninAnjali Pandey, Kiranjeet Kour, Sarang Bani, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2023
Association of air pollution and COVID-19 in IndiaRahul Tyagi, Saurabh Mittal, Karan Madan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2014
The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancerGreg Coffey, Andreas Betz, Francis DeGuzman, et al.
Blood Advances|August 24, 2018
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitorsManu T Kalathottukaren, A Louise Creagh, Srinivas Abbina, et al.
Plos Biology|June 13, 2022
Context-dependent reversal of odorant preference is driven by inversion of the response in a single sensory neuron typeMunzareen Khan, Anna H Hartmann, Michael P O'Donnell, et al.
Blood|October 26, 2011
SYK inhibition and response prediction in diffuse large B-cell lymphomaShuhua Cheng, Greg Coffey, X Hannah Zhang, et al.
Oncotarget|November 18, 2015
Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphomaJiao Ma, Wei Xing, Greg Coffey, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|December 25, 2012
Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2)Craig E Hughes, Uma Sinha, Anjali Pandey, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2010
Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosisIvo Cornelissen, Daniel Palmer, Tovo David, et al.
RSC Advances|December 4, 2025
Preclinical validation of magnetic hyperthermia therapy for locally advanced oral cancer treatmentPriyadharshni Sriram, Anjali Pandey, Aganiya Gopalakrishnan, et al.
Phytotherapy Research : PTR|March 17, 2009
Amelioration of adjuvant induced arthritis by apocyninAnjali Pandey, Kiranjeet Kour, Sarang Bani, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2023
Association of air pollution and COVID-19 in IndiaRahul Tyagi, Saurabh Mittal, Karan Madan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2014
The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancerGreg Coffey, Andreas Betz, Francis DeGuzman, et al.
Blood Advances|August 24, 2018
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitorsManu T Kalathottukaren, A Louise Creagh, Srinivas Abbina, et al.
Plos Biology|June 13, 2022
Context-dependent reversal of odorant preference is driven by inversion of the response in a single sensory neuron typeMunzareen Khan, Anna H Hartmann, Michael P O'Donnell, et al.
Blood|October 26, 2011
SYK inhibition and response prediction in diffuse large B-cell lymphomaShuhua Cheng, Greg Coffey, X Hannah Zhang, et al.
Oncotarget|November 18, 2015
Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphomaJiao Ma, Wei Xing, Greg Coffey, et al.
Pageof 8